Rank | Gene Set | Z-score |
---|---|---|
1 | neutrophil activation involved in immune response (GO:0002283) | 5.17979106 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.01523737 |
3 | response to peptidoglycan (GO:0032494) | 4.70158097 |
4 | cellular extravasation (GO:0045123) | 4.07657709 |
5 | positive regulation of B cell differentiation (GO:0045579) | 4.04645915 |
6 | detection of other organism (GO:0098543) | 3.97982789 |
7 | immunoglobulin mediated immune response (GO:0016064) | 3.96754804 |
8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.92543918 |
9 | detection of bacterium (GO:0016045) | 3.91673260 |
10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.91020494 |
11 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.77361988 |
12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.70585214 |
13 | positive regulation by symbiont of host defense response (GO:0052509) | 3.58908544 |
14 | modulation by symbiont of host defense response (GO:0052031) | 3.58908544 |
15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.58908544 |
16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.58908544 |
17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.58908544 |
18 | modulation by symbiont of host immune response (GO:0052553) | 3.58908544 |
19 | microglial cell activation (GO:0001774) | 3.57827843 |
20 | negative regulation of interleukin-12 production (GO:0032695) | 3.51314848 |
21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.50458835 |
22 | regulation of mast cell degranulation (GO:0043304) | 3.49317447 |
23 | neutrophil activation (GO:0042119) | 3.47347373 |
24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.45837995 |
25 | negative regulation of cell killing (GO:0031342) | 3.45837995 |
26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.41946149 |
27 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.40590133 |
28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39605458 |
29 | neutrophil mediated immunity (GO:0002446) | 3.30759220 |
30 | macrophage activation involved in immune response (GO:0002281) | 3.30042300 |
31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.25804788 |
32 | granulocyte activation (GO:0036230) | 3.24981882 |
33 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21383536 |
34 | B cell mediated immunity (GO:0019724) | 3.17511190 |
35 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.16098207 |
36 | defense response to protozoan (GO:0042832) | 3.12305668 |
37 | myeloid cell activation involved in immune response (GO:0002275) | 3.11233943 |
38 | response to muramyl dipeptide (GO:0032495) | 3.11232156 |
39 | response to protozoan (GO:0001562) | 3.08414846 |
40 | negative regulation of growth of symbiont in host (GO:0044130) | 3.07578176 |
41 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.07578176 |
42 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.07578176 |
43 | regulation of growth of symbiont in host (GO:0044126) | 3.07578176 |
44 | detection of external biotic stimulus (GO:0098581) | 3.06713329 |
45 | autophagic vacuole fusion (GO:0000046) | 3.05152575 |
46 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04923482 |
47 | positive regulation of antigen processing and presentation (GO:0002579) | 3.04253978 |
48 | regulation of B cell differentiation (GO:0045577) | 3.03421840 |
49 | leukocyte aggregation (GO:0070486) | 3.00692818 |
50 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.99758206 |
51 | response to host immune response (GO:0052572) | 2.99758206 |
52 | macrophage activation (GO:0042116) | 2.99715174 |
53 | positive regulation of mast cell activation (GO:0033005) | 2.98399155 |
54 | mature B cell differentiation involved in immune response (GO:0002313) | 2.97792490 |
55 | regulation of leukocyte degranulation (GO:0043300) | 2.97304108 |
56 | regulation of antigen processing and presentation (GO:0002577) | 2.96913489 |
57 | regulation of mast cell activation (GO:0033003) | 2.95444217 |
58 | positive regulation of mast cell degranulation (GO:0043306) | 2.93980328 |
59 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.93980328 |
60 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.93891679 |
61 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.93839343 |
62 | definitive hemopoiesis (GO:0060216) | 2.93373149 |
63 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.92215880 |
64 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91890069 |
65 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.91028531 |
66 | thrombin receptor signaling pathway (GO:0070493) | 2.89215173 |
67 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.88930436 |
68 | leukocyte degranulation (GO:0043299) | 2.84123408 |
69 | positive regulation of granulocyte differentiation (GO:0030854) | 2.83630553 |
70 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.82791223 |
71 | B cell receptor signaling pathway (GO:0050853) | 2.81572195 |
72 | respiratory burst (GO:0045730) | 2.81460632 |
73 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.79753997 |
74 | type I interferon signaling pathway (GO:0060337) | 2.77318473 |
75 | cellular response to type I interferon (GO:0071357) | 2.77318473 |
76 | regulation of chemokine biosynthetic process (GO:0045073) | 2.77281466 |
77 | response to type I interferon (GO:0034340) | 2.75294890 |
78 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.74710588 |
79 | detection of biotic stimulus (GO:0009595) | 2.72751616 |
80 | germinal center formation (GO:0002467) | 2.72193389 |
81 | negative regulation of T cell mediated immunity (GO:0002710) | 2.72048604 |
82 | regulation of hypersensitivity (GO:0002883) | 2.68898719 |
83 | response to host (GO:0075136) | 2.68735617 |
84 | response to host defenses (GO:0052200) | 2.68735617 |
85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.68735617 |
86 | negative regulation of interleukin-8 production (GO:0032717) | 2.66711790 |
87 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.65439110 |
88 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.64831772 |
89 | positive regulation of interleukin-17 production (GO:0032740) | 2.63760340 |
90 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.63568965 |
91 | response to interferon-beta (GO:0035456) | 2.62798944 |
92 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.62245723 |
93 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.60891403 |
94 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.60130996 |
95 | myeloid leukocyte mediated immunity (GO:0002444) | 2.59670591 |
96 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.57844125 |
97 | regulation of interferon-alpha production (GO:0032647) | 2.56849010 |
98 | T-helper 1 type immune response (GO:0042088) | 2.56743468 |
99 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.55449340 |
100 | cellular response to exogenous dsRNA (GO:0071360) | 2.54597694 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.23613567 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.10645197 |
3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.77709685 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.60698725 |
5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.57987902 |
6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.54782281 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.37952947 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88571603 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.87807298 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.85287242 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.82598474 |
12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.68159213 |
13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.67750411 |
14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.67593659 |
15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.61455585 |
16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.60843523 |
17 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.59338334 |
18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.53851582 |
19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.50683040 |
20 | MYB_26560356_Chip-Seq_TH2_Human | 2.35836719 |
21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.24536296 |
22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.24213549 |
23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.18074506 |
24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.16044429 |
25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.10030733 |
26 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09958223 |
27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08954109 |
28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.07613893 |
29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04219579 |
30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97551670 |
31 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.91862200 |
32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86992778 |
33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.82938736 |
34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82513412 |
35 | MAF_26560356_Chip-Seq_TH1_Human | 1.81702549 |
36 | MYB_26560356_Chip-Seq_TH1_Human | 1.78583868 |
37 | GATA1_19941826_ChIP-Seq_K562_Human | 1.77534045 |
38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.77189721 |
39 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74027841 |
40 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71900767 |
41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69619409 |
42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67363043 |
43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66724305 |
44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64173366 |
45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63794174 |
46 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.62920494 |
47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62230703 |
48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58156685 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54763440 |
50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.51285527 |
51 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50968877 |
52 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43908582 |
53 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40075703 |
54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.37600925 |
55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36021046 |
56 | MYC_22102868_ChIP-Seq_BL_Human | 1.34447649 |
57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33080751 |
58 | GATA2_19941826_ChIP-Seq_K562_Human | 1.31691755 |
59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24310219 |
60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22446717 |
61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21143619 |
62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20355584 |
63 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20257965 |
64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19255163 |
65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18309775 |
66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18111708 |
67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17626421 |
68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17619227 |
69 | MAF_26560356_Chip-Seq_TH2_Human | 1.17258646 |
70 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.16342332 |
71 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15868469 |
72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13436655 |
73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.11265466 |
74 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.09627644 |
75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07627874 |
76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.07111017 |
77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06245148 |
78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03567675 |
79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03251424 |
80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01790935 |
81 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99655794 |
82 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.98926600 |
83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96926168 |
84 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95411887 |
85 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93482831 |
86 | * P300_27268052_Chip-Seq_Bcells_Human | 0.92073243 |
87 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91163838 |
88 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.88446851 |
89 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85521879 |
90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84825848 |
91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.84145149 |
92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83214955 |
93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82279568 |
94 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.81682465 |
95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.81135137 |
96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.79778438 |
97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.76434845 |
98 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76151663 |
99 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.73563757 |
100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.73022663 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 4.92036407 |
2 | MP0003724_increased_susceptibility_to | 3.91841259 |
3 | MP0001835_abnormal_antigen_presentation | 3.58610694 |
4 | MP0003436_decreased_susceptibility_to | 3.33956397 |
5 | MP0005464_abnormal_platelet_physiology | 3.08183941 |
6 | MP0006082_CNS_inflammation | 2.80380659 |
7 | MP0009785_altered_susceptibility_to | 2.73704150 |
8 | MP0002419_abnormal_innate_immunity | 2.72077650 |
9 | MP0002148_abnormal_hypersensitivity_rea | 2.69796857 |
10 | MP0005025_abnormal_response_to | 2.69664169 |
11 | MP0001545_abnormal_hematopoietic_system | 2.60518992 |
12 | MP0005397_hematopoietic_system_phenotyp | 2.60518992 |
13 | MP0005000_abnormal_immune_tolerance | 2.59283034 |
14 | MP0000465_gastrointestinal_hemorrhage | 2.49709111 |
15 | MP0001800_abnormal_humoral_immune | 2.42085649 |
16 | MP0005387_immune_system_phenotype | 2.26506519 |
17 | MP0001790_abnormal_immune_system | 2.26506519 |
18 | MP0005671_abnormal_response_to | 2.26147479 |
19 | MP0002452_abnormal_antigen_presenting | 2.25686386 |
20 | MP0002723_abnormal_immune_serum | 2.21984438 |
21 | MP0002420_abnormal_adaptive_immunity | 2.16428359 |
22 | MP0010155_abnormal_intestine_physiology | 2.16108131 |
23 | MP0009278_abnormal_bone_marrow | 2.16096838 |
24 | MP0001819_abnormal_immune_cell | 2.15071406 |
25 | MP0000685_abnormal_immune_system | 2.04904604 |
26 | MP0003763_abnormal_thymus_physiology | 1.97152753 |
27 | MP0003806_abnormal_nucleotide_metabolis | 1.94930384 |
28 | MP0003300_gastrointestinal_ulcer | 1.88827189 |
29 | MP0002396_abnormal_hematopoietic_system | 1.87166679 |
30 | MP0001533_abnormal_skeleton_physiology | 1.81478823 |
31 | MP0001845_abnormal_inflammatory_respons | 1.78278538 |
32 | MP0002398_abnormal_bone_marrow | 1.74118361 |
33 | MP0002405_respiratory_system_inflammati | 1.73619804 |
34 | MP0009764_decreased_sensitivity_to | 1.71008293 |
35 | MP0003191_abnormal_cellular_cholesterol | 1.67153015 |
36 | MP0000716_abnormal_immune_system | 1.66042329 |
37 | MP0008004_abnormal_stomach_pH | 1.59234037 |
38 | MP0009333_abnormal_splenocyte_physiolog | 1.56466039 |
39 | MP0005058_abnormal_lysosome_morphology | 1.54429677 |
40 | MP0003172_abnormal_lysosome_physiology | 1.53645244 |
41 | MP0008469_abnormal_protein_level | 1.52962145 |
42 | MP0003075_altered_response_to | 1.49763369 |
43 | MP0004947_skin_inflammation | 1.49620365 |
44 | MP0003656_abnormal_erythrocyte_physiolo | 1.49497526 |
45 | MP0000689_abnormal_spleen_morphology | 1.48125516 |
46 | MP0003866_abnormal_defecation | 1.45472957 |
47 | MP0004808_abnormal_hematopoietic_stem | 1.43821919 |
48 | MP0002722_abnormal_immune_system | 1.43734331 |
49 | MP0005166_decreased_susceptibility_to | 1.43664315 |
50 | MP0002429_abnormal_blood_cell | 1.41002400 |
51 | MP0002132_abnormal_respiratory_system | 1.39655131 |
52 | MP0001663_abnormal_digestive_system | 1.39127204 |
53 | MP0003183_abnormal_peptide_metabolism | 1.35575693 |
54 | MP0001853_heart_inflammation | 1.23309563 |
55 | MP0000858_altered_metastatic_potential | 1.22600622 |
56 | MP0003828_pulmonary_edema | 1.19565407 |
57 | MP0001851_eye_inflammation | 1.18681983 |
58 | MP0009763_increased_sensitivity_to | 1.14507013 |
59 | MP0001873_stomach_inflammation | 1.12431473 |
60 | MP0002166_altered_tumor_susceptibility | 1.10820972 |
61 | MP0002139_abnormal_hepatobiliary_system | 1.06495416 |
62 | MP0000343_altered_response_to | 1.06434548 |
63 | MP0005164_abnormal_response_to | 0.99855196 |
64 | MP0005451_abnormal_body_composition | 0.94876930 |
65 | MP0000703_abnormal_thymus_morphology | 0.92646080 |
66 | MP0009765_abnormal_xenobiotic_induced | 0.92326109 |
67 | MP0009840_abnormal_foam_cell | 0.92200315 |
68 | MP0002998_abnormal_bone_remodeling | 0.92152107 |
69 | MP0002138_abnormal_hepatobiliary_system | 0.90049253 |
70 | MP0002006_tumorigenesis | 0.89592159 |
71 | MP0005310_abnormal_salivary_gland | 0.86867941 |
72 | MP0005381_digestive/alimentary_phenotyp | 0.86732361 |
73 | MP0005165_increased_susceptibility_to | 0.84613161 |
74 | MP0003448_altered_tumor_morphology | 0.83355734 |
75 | MP0008260_abnormal_autophagy | 0.82629588 |
76 | MP0006054_spinal_hemorrhage | 0.82405635 |
77 | MP0005075_abnormal_melanosome_morpholog | 0.81336800 |
78 | MP0001664_abnormal_digestion | 0.81122987 |
79 | MP0002019_abnormal_tumor_incidence | 0.80488898 |
80 | MP0000490_abnormal_crypts_of | 0.78741536 |
81 | MP0005360_urolithiasis | 0.77769825 |
82 | MP0005390_skeleton_phenotype | 0.77276260 |
83 | MP0000604_amyloidosis | 0.77019506 |
84 | MP0005319_abnormal_enzyme/_coenzyme | 0.76366903 |
85 | MP0004883_abnormal_blood_vessel | 0.72602245 |
86 | MP0000249_abnormal_blood_vessel | 0.72288092 |
87 | MP0005535_abnormal_body_temperature | 0.71913167 |
88 | MP0004147_increased_porphyrin_level | 0.71444844 |
89 | MP0009643_abnormal_urine_homeostasis | 0.69334249 |
90 | MP0001764_abnormal_homeostasis | 0.68464577 |
91 | MP0005085_abnormal_gallbladder_physiolo | 0.67968978 |
92 | MP0005083_abnormal_biliary_tract | 0.66202432 |
93 | MP0005365_abnormal_bile_salt | 0.65643068 |
94 | MP0004510_myositis | 0.61618742 |
95 | MP0000609_abnormal_liver_physiology | 0.59956911 |
96 | MP0000015_abnormal_ear_pigmentation | 0.59323917 |
97 | MP0005376_homeostasis/metabolism_phenot | 0.58931592 |
98 | MP0000681_abnormal_thyroid_gland | 0.58917736 |
99 | MP0002136_abnormal_kidney_physiology | 0.57899742 |
100 | MP0005084_abnormal_gallbladder_morpholo | 0.56736931 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.85407844 |
2 | Myositis (HP:0100614) | 4.62966672 |
3 | Prolonged bleeding time (HP:0003010) | 4.50586307 |
4 | Eczematoid dermatitis (HP:0000976) | 4.46247795 |
5 | Recurrent abscess formation (HP:0002722) | 4.45707878 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.40899693 |
7 | Stomatitis (HP:0010280) | 4.20564885 |
8 | Petechiae (HP:0000967) | 4.16682054 |
9 | Chronic obstructive pulmonary disease (HP:0006510) | 3.89611076 |
10 | Obstructive lung disease (HP:0006536) | 3.89611076 |
11 | Abnormality of macrophages (HP:0004311) | 3.85098766 |
12 | Orchitis (HP:0100796) | 3.84085909 |
13 | Epistaxis (HP:0000421) | 3.68641511 |
14 | Retrobulbar optic neuritis (HP:0100654) | 3.53985737 |
15 | Optic neuritis (HP:0100653) | 3.53985737 |
16 | Recurrent fungal infections (HP:0002841) | 3.52748746 |
17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.46822311 |
18 | Purpura (HP:0000979) | 3.46669943 |
19 | Thrombocytosis (HP:0001894) | 3.39551191 |
20 | Meningitis (HP:0001287) | 3.34247829 |
21 | Gingival bleeding (HP:0000225) | 3.29430611 |
22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.24148309 |
23 | Mediastinal lymphadenopathy (HP:0100721) | 3.19282771 |
24 | Recurrent skin infections (HP:0001581) | 3.11616952 |
25 | Vasculitis (HP:0002633) | 3.03416987 |
26 | Granulocytopenia (HP:0001913) | 2.99641006 |
27 | Autoimmune hemolytic anemia (HP:0001890) | 2.94622342 |
28 | Recurrent viral infections (HP:0004429) | 2.93322807 |
29 | Panhypogammaglobulinemia (HP:0003139) | 2.92187959 |
30 | Increased IgE level (HP:0003212) | 2.91602660 |
31 | Autoimmune thrombocytopenia (HP:0001973) | 2.90977301 |
32 | Encephalitis (HP:0002383) | 2.90348985 |
33 | Recurrent cutaneous fungal infections (HP:0011370) | 2.84823528 |
34 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.84823528 |
35 | Urticaria (HP:0001025) | 2.83791745 |
36 | Leukocytosis (HP:0001974) | 2.83475394 |
37 | Chest pain (HP:0100749) | 2.80667921 |
38 | Arterial thrombosis (HP:0004420) | 2.77323973 |
39 | Agammaglobulinemia (HP:0004432) | 2.75278451 |
40 | Pulmonary infiltrates (HP:0002113) | 2.75068438 |
41 | Keratoconjunctivitis sicca (HP:0001097) | 2.74129637 |
42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.73636071 |
43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.73636071 |
44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.73636071 |
45 | Acute lymphatic leukemia (HP:0006721) | 2.72981855 |
46 | Abnormality of the prostate (HP:0008775) | 2.70622481 |
47 | Abnormality of B cell number (HP:0010975) | 2.66030652 |
48 | Abnormality of iron homeostasis (HP:0011031) | 2.64103439 |
49 | Systemic lupus erythematosus (HP:0002725) | 2.63660253 |
50 | Hemoptysis (HP:0002105) | 2.63312762 |
51 | Cellulitis (HP:0100658) | 2.61737478 |
52 | Hypergammaglobulinemia (HP:0010702) | 2.61494136 |
53 | Gangrene (HP:0100758) | 2.61219114 |
54 | Gastrointestinal infarctions (HP:0005244) | 2.59523956 |
55 | Keratoconjunctivitis (HP:0001096) | 2.56860199 |
56 | Pustule (HP:0200039) | 2.56040472 |
57 | Abnormality of T cell physiology (HP:0011840) | 2.55543164 |
58 | Amyloidosis (HP:0011034) | 2.55428306 |
59 | Increased IgM level (HP:0003496) | 2.51030557 |
60 | Increased serum ferritin (HP:0003281) | 2.50703679 |
61 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.49464706 |
62 | Pulmonary embolism (HP:0002204) | 2.48214889 |
63 | Increased cerebral lipofuscin (HP:0011813) | 2.48081308 |
64 | Spontaneous hematomas (HP:0007420) | 2.44916710 |
65 | Eosinophilia (HP:0001880) | 2.44795710 |
66 | Abnormality of T cells (HP:0002843) | 2.42456089 |
67 | Chronic otitis media (HP:0000389) | 2.40123308 |
68 | Gingivitis (HP:0000230) | 2.39155479 |
69 | Inflammation of the large intestine (HP:0002037) | 2.38982828 |
70 | Dysostosis multiplex (HP:0000943) | 2.38457581 |
71 | Episodic fever (HP:0001954) | 2.37475051 |
72 | Gastrointestinal inflammation (HP:0004386) | 2.36358180 |
73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34947929 |
74 | Abnormal platelet volume (HP:0011876) | 2.32310790 |
75 | Impaired platelet aggregation (HP:0003540) | 2.32275374 |
76 | Abnormal platelet function (HP:0011869) | 2.32275374 |
77 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.30090064 |
78 | Vacuolated lymphocytes (HP:0001922) | 2.29390209 |
79 | Hepatosplenomegaly (HP:0001433) | 2.28557149 |
80 | Skin rash (HP:0000988) | 2.28408506 |
81 | Polyneuropathy (HP:0001271) | 2.27937356 |
82 | Abnormality of T cell number (HP:0011839) | 2.27301467 |
83 | Interstitial pulmonary disease (HP:0006530) | 2.21481446 |
84 | Abnormality of the pleura (HP:0002103) | 2.20564277 |
85 | B lymphocytopenia (HP:0010976) | 2.19513691 |
86 | Thrombophlebitis (HP:0004418) | 2.17642735 |
87 | Menorrhagia (HP:0000132) | 2.17014660 |
88 | Joint swelling (HP:0001386) | 2.16715365 |
89 | Chronic diarrhea (HP:0002028) | 2.12722009 |
90 | Skin ulcer (HP:0200042) | 2.10034705 |
91 | Osteomyelitis (HP:0002754) | 2.08334984 |
92 | Colitis (HP:0002583) | 2.07750984 |
93 | T lymphocytopenia (HP:0005403) | 2.07739475 |
94 | Anorexia (HP:0002039) | 2.03943304 |
95 | Loss of speech (HP:0002371) | 2.02447775 |
96 | Hypertensive crisis (HP:0100735) | 2.01004437 |
97 | Vertigo (HP:0002321) | 2.00638777 |
98 | Abnormality of eosinophils (HP:0001879) | 1.99573225 |
99 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.99520813 |
100 | Increased mean platelet volume (HP:0011877) | 1.98693934 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP2K3 | 3.73731796 |
2 | RIPK4 | 3.28266978 |
3 | MAP4K1 | 2.95806060 |
4 | ERN1 | 2.73164067 |
5 | JAK3 | 2.61408680 |
6 | TAOK3 | 2.55331037 |
7 | MAP3K11 | 2.52425609 |
8 | TAOK2 | 2.50055037 |
9 | KIT | 2.48409089 |
10 | MAP3K3 | 2.43364982 |
11 | FES | 2.38879875 |
12 | TXK | 2.24363768 |
13 | TAOK1 | 2.21644472 |
14 | TBK1 | 2.12766198 |
15 | IRAK4 | 2.09028575 |
16 | TYK2 | 2.06429958 |
17 | MAP3K14 | 2.05006399 |
18 | BLK | 2.02385456 |
19 | BTK | 1.96205802 |
20 | ZAP70 | 1.92414070 |
21 | MKNK2 | 1.91451049 |
22 | SYK | 1.88199395 |
23 | TEC | 1.85490533 |
24 | MATK | 1.85459521 |
25 | BMPR2 | 1.83041799 |
26 | IKBKE | 1.72140785 |
27 | GRK6 | 1.68519286 |
28 | CSK | 1.64650578 |
29 | MKNK1 | 1.57745915 |
30 | IKBKB | 1.53741693 |
31 | NME2 | 1.52582097 |
32 | CSF1R | 1.51466155 |
33 | TNK2 | 1.44026981 |
34 | LYN | 1.33206165 |
35 | MAP3K1 | 1.31642744 |
36 | TESK2 | 1.31489424 |
37 | HCK | 1.31008197 |
38 | IRAK3 | 1.26024590 |
39 | ITK | 1.24547603 |
40 | PRPF4B | 1.22330089 |
41 | LCK | 1.10613413 |
42 | IRAK1 | 1.09839296 |
43 | ABL2 | 1.09430077 |
44 | BCKDK | 1.05358611 |
45 | MAP3K5 | 0.99480304 |
46 | JAK2 | 0.99321075 |
47 | PIK3CG | 0.99141093 |
48 | MAP3K6 | 0.97867438 |
49 | JAK1 | 0.96726386 |
50 | PIM2 | 0.89413202 |
51 | GRK7 | 0.88835429 |
52 | KDR | 0.88380791 |
53 | SCYL2 | 0.87117337 |
54 | MAP2K6 | 0.84730645 |
55 | PRKCQ | 0.82667754 |
56 | MAP3K13 | 0.82229315 |
57 | HIPK2 | 0.80658749 |
58 | FGR | 0.80567942 |
59 | MAP4K2 | 0.78461262 |
60 | FLT3 | 0.71927076 |
61 | EPHB1 | 0.67438458 |
62 | TGFBR2 | 0.64725543 |
63 | NUAK1 | 0.63947469 |
64 | TRPM7 | 0.63876862 |
65 | PRKG2 | 0.58626547 |
66 | IRAK2 | 0.58472762 |
67 | ACVR1B | 0.57822701 |
68 | PIM1 | 0.52511904 |
69 | CDK19 | 0.52140040 |
70 | DAPK2 | 0.51237258 |
71 | MAP2K2 | 0.51233047 |
72 | CDK6 | 0.50720554 |
73 | PDK1 | 0.49051143 |
74 | LRRK2 | 0.48371766 |
75 | ABL1 | 0.47503186 |
76 | MARK3 | 0.46513173 |
77 | EPHA3 | 0.46118399 |
78 | PRKCD | 0.44028625 |
79 | STK10 | 0.41033885 |
80 | PDPK1 | 0.39833044 |
81 | FGFR3 | 0.38114396 |
82 | RPS6KB2 | 0.37277802 |
83 | FYN | 0.36089583 |
84 | MST4 | 0.35064239 |
85 | RPS6KL1 | 0.34224280 |
86 | RPS6KC1 | 0.34224280 |
87 | ADRBK2 | 0.33990682 |
88 | MAPK4 | 0.33677385 |
89 | BMX | 0.33183537 |
90 | MAP3K2 | 0.32068356 |
91 | RPS6KA6 | 0.30447750 |
92 | PTK2B | 0.29611901 |
93 | MAPK3 | 0.27964929 |
94 | IGF1R | 0.27346478 |
95 | DAPK1 | 0.26979447 |
96 | MAPKAPK2 | 0.24707617 |
97 | MAPK11 | 0.23577044 |
98 | TLK1 | 0.22560060 |
99 | MAP3K7 | 0.22481818 |
100 | PIK3CA | 0.21713217 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Asthma_Homo sapiens_hsa05310 | 3.34520549 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 3.12462193 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.02110790 |
4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.92301081 |
5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.87761569 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.75631691 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.52995759 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.38111784 |
9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.30744316 |
10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.21679837 |
11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17587914 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.99958758 |
13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.95549170 |
14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.93917630 |
15 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.90717199 |
16 | Tuberculosis_Homo sapiens_hsa05152 | 1.89562480 |
17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89001924 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.86564380 |
19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85889319 |
20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.76609942 |
21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73259610 |
22 | Malaria_Homo sapiens_hsa05144 | 1.63672169 |
23 | Legionellosis_Homo sapiens_hsa05134 | 1.58349781 |
24 | Platelet activation_Homo sapiens_hsa04611 | 1.57110561 |
25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56556250 |
26 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.53940993 |
27 | Pertussis_Homo sapiens_hsa05133 | 1.53917457 |
28 | Influenza A_Homo sapiens_hsa05164 | 1.51356181 |
29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47208167 |
30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44361004 |
31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.44233738 |
32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42031535 |
33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.36325380 |
34 | Measles_Homo sapiens_hsa05162 | 1.34346709 |
35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32125314 |
36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29645476 |
37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25789335 |
38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22102969 |
39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17952711 |
40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17428939 |
41 | Lysosome_Homo sapiens_hsa04142 | 1.16267432 |
42 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14788688 |
43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08721329 |
44 | Salmonella infection_Homo sapiens_hsa05132 | 1.06914678 |
45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05243569 |
46 | Phagosome_Homo sapiens_hsa04145 | 1.03111139 |
47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02671262 |
48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97475339 |
49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95946647 |
50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95356408 |
51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94342506 |
52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89532608 |
53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87562168 |
54 | Hepatitis C_Homo sapiens_hsa05160 | 0.85267129 |
55 | Shigellosis_Homo sapiens_hsa05131 | 0.80919098 |
56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.80655233 |
57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78189832 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73358759 |
59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70978607 |
60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70576118 |
61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68055488 |
62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67751013 |
63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66088607 |
64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65199462 |
65 | Hepatitis B_Homo sapiens_hsa05161 | 0.64956160 |
66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61824072 |
67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61009173 |
68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60839003 |
69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60164361 |
70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57627101 |
71 | * Amoebiasis_Homo sapiens_hsa05146 | 0.55629114 |
72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55358350 |
73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54698390 |
74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51048509 |
75 | Apoptosis_Homo sapiens_hsa04210 | 0.50822706 |
76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50311983 |
77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.49290757 |
78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47459573 |
79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43992776 |
80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43631088 |
81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42123261 |
82 | Peroxisome_Homo sapiens_hsa04146 | 0.42013828 |
83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40204004 |
84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40047399 |
85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38711997 |
86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38619232 |
87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.38538396 |
88 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37351422 |
89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35493232 |
90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34948120 |
91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32891373 |
92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32771369 |
93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32031553 |
94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31440611 |
95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29770722 |
96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29152832 |
97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26781331 |
98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.26322114 |
99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25478678 |
100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.22836066 |